| Medical and Health Sciences | 2021-2025 | 857 | DK 10 | 99.80 |
| Rheumatology | Lifetime | 132 | DK 3 | 99.46 |
| Cancer Research | Lifetime | 429 | DK 11 | 97.38 |
| Clinical Pharmacology | Lifetime | 640 | DK 11 | 97.19 |
| Hepatology | Lifetime | 443 | DK 5 | 96.11 |
| Orthopedics and Sports Medicine | Lifetime | 642 | DK 23 | 93.23 |
| Immunology and Allergy | Lifetime | 532 | DK 18 | 90.26 |
| Nephrology | Lifetime | 992 | DK 14 | 80.06 |
| Rheumatology | 2021-2025 | 62 | DK 2 | 98.56 |
| Epidemiology | 2021-2025 | 337 | DK 6 | 97.30 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 520 | DK 4 | 94.29 |
| Oncology | 2021-2025 | 599 | DK 6 | 91.20 |
| Immunology and Allergy | 2021-2025 | 120 | DK 6 | 89.39 |
| Pathology and Forensic Medicine | 2021-2025 | 382 | DK 9 | 85.46 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 473 | DK 15 | 85.61 |
| Clinical Pharmacology | 2021-2025 | 364 | DK 6 | 83.90 |
| Cancer Research | 2021-2025 | 326 | DK 4 | 80.17 |
| Hepatology | 2021-2025 | 269 | DK 3 | 83.35 |
| Immunology | 2021-2025 | 753 | DK 9 | 75.48 |
| Nephrology | 2021-2025 | 309 | DK 2 | 75.09 |
| Genetics | 2021-2025 | 807 | DK 15 | 73.35 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 72 | DK 2 | 99.58 |
| Inflammatory mediators and NSAID effects | Lifetime | 77 | DK 2 | 99.25 |
| Bone Metabolism and Diseases | Lifetime | 70 | DK 1 | 99.39 |
| Liver physiology and pathology | Lifetime | 78 | DK 1 | 99.11 |
| Protease and Inhibitor Mechanisms | Lifetime | 106 | DK 3 | 99.05 |
| Bone health and treatments | Lifetime | 125 | DK 3 | 99.30 |
| Liver Disease Diagnosis and Treatment | Lifetime | 742 | DK 14 | 99.08 |
| Cell Adhesion Molecules Research | Lifetime | 378 | DK 5 | 98.73 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 225 | DK 4 | 99.05 |
| Bone health and osteoporosis research | Lifetime | 333 | DK 8 | 98.32 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 478 | DK 5 | 97.59 |
| Connective tissue disorders research | Lifetime | 273 | DK 2 | 96.56 |
| Connective Tissue Growth Factor Research | Lifetime | 57 | DK 1 | 96.48 |
| Liver Diseases and Immunity | Lifetime | 352 | DK 3 | 97.25 |
| TGF-β signaling in diseases | Lifetime | 300 | DK 1 | 95.66 |
| Systemic Sclerosis and Related Diseases | Lifetime | 625 | DK 9 | 95.89 |
| Spondyloarthritis Studies and Treatments | Lifetime | 676 | DK 19 | 93.87 |
| Cell Adhesion Molecules Research | 2021-2025 | 9 | DK 1 | 96.65 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 8 | DK 1 | 98.21 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 40 | DK 3 | 98.54 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 15 | DK 1 | 96.75 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 473 | DK 7 | 97.75 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 152 | DK 2 | 97.15 |
| Liver physiology and pathology | 2021-2025 | 75 | DK 1 | 92.35 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 270 | DK 10 | 95.81 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 182 | DK 3 | 94.24 |
| Liver Diseases and Immunity | 2021-2025 | 261 | DK 2 | 91.07 |
| Peptidase Inhibition and Analysis | 2021-2025 | 967 | DK 3 | 86.10 |
| S100 Proteins and Annexins | 2021-2025 | 226 | DK 1 | 80.37 |
| Neuropeptides and Animal Physiology | 2021-2025 | 428 | DK 18 | 80.71 |
| TGF-β signaling in diseases | 2021-2025 | 79 | DK 3 | 76.08 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 393 | DK 8 | 74.73 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 582 | DK 4 | 70.52 |
| Occupational exposure and asthma | 2021-2025 | 304 | DK 25 | 71.92 |
| Fibroblast Growth Factor Research | 2021-2025 | 456 | DK 7 | 70.04 |
| Occupational and environmental lung diseases | 2021-2025 | 995 | DK 10 | 68.17 |
| Connective Tissue Growth Factor Research | 2021-2025 | 97 | DK 1 | 61.82 |
| Signaling Pathways in Disease | 2021-2025 | 964 | DK 6 | 45.33 |
| Dupuytren's Contracture and Treatments | 2021-2025 | 276 | DK 1 | 36.85 |
| Apelin-related biomedical research | 2021-2025 | 752 | DK 2 | 32.85 |
| Inflammation biomarkers and pathways | 2021-2025 | 569 | DK 11 | 28.27 |